A Study of PROCRIT (Epoetin Alfa) 80,000 Units (U) Once Every Four Weeks (Q4W) vs. 40,000 U Once Every Two Weeks (Q2W) in Cancer Patients Not Receiving Chemotherapy

This study has been terminated.

(Study stopped as it would not address important survival concerns raised in other recently conducted clinical studies.)

Sponsor:

Collaborator:

Ortho Biotech Products, L.P.

Information provided by:

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

ClinicalTrials.gov Identifier:

NCT00306267

First received: March 21, 2006

Last updated: May 17, 2011

Last verified: March 2010

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	May 2007
Estimated Primary Completion Date:	No date given